Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

2021

  • Quantum Cloud Growth and the Future of Computing
    November 3rd, 2021· 2.4 min·
    Quantum Cloud Growth and the Future of Computing

    Just a few years ago, truly viable and useful quantum computing was

  • PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million
    September 30th, 2021· 1.3 min·
    PolarisQB, Developers of First Quantum Drug Discovery Platform, Announces Seed Investment of $2.1 Million

    PolarisQB, the Durham based developer of the world’s first drug discovery software

  • Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation
    July 8th, 2021· 1 min·
    Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation

    Last year Polarisqb  began our journey to revolutionize the world of drug

  • Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases
    June 4th, 2021· 2.5 min·
    Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases

    PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial

  • PolarisQB Announce Hiring of Pharmacologist Ian Reynolds
    May 10th, 2021· 2.2 min·
    PolarisQB Announce Hiring of Pharmacologist Ian Reynolds

    Polarisqb  is proud to add Dr. Ian Reynolds, a world renowned expert

  • PM 360 Recognizes PolarisQB as a 2020 Innovative Startup
    January 11th, 2021· 1.4 min·
    PM 360 Recognizes PolarisQB as a 2020 Innovative Startup

    PM 360 is one of the leading magazines in the pharmaceutical marketing world,

  • Accelerating Drug Discovery Through Collaboration
    January 4th, 2021· 1.8 min·
    Accelerating Drug Discovery Through Collaboration

    Fujitsu has been working with POLARISqb as we build the first drug

Search
Recent Posts
  • An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site February 28, 2025
  • Combinatorial Optimization vs. Physical Simulation January 19, 2025
  • Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats January 12, 2025
Categories
  • Blog (14)
  • News (43)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2025 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top